---
document_datetime: 2025-05-06 16:50:49
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/vyjuvek-epar-all-authorised-presentations_en.pdf
document_name: vyjuvek-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6541902
conversion_datetime: 2025-12-31 02:10:55.852852
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EMA Number       | (Invented) name   | Strength       | Pharmaceutical Form        | Route of Administration   | Immediate Packaging                       | Content (concentration)       | Pack size                          |
|------------------|-------------------|----------------|----------------------------|---------------------------|-------------------------------------------|-------------------------------|------------------------------------|
| EU/1/25/1918/001 | Vyjuvek           | 5 x 10‚Åπ PFU/ml | Suspension and gel for gel | Cutaneous use             | suspension: vial (COC); gel: vial (glass) | suspension: 1 ml; gel: 1.5 ml | 1 vial (suspension) + 1 vial (gel) |